Stocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands

Dow Jones01-09 07:32

By Katherine Hamilton

Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday.

Olin cut its fourth-quarter outlook, citing a slowdown in operations at its Freeport, Texas, facility and a decline in chlorine demand. The stock fell 7.8% to $20.80 after the bell.

Pacira BioSciences' preliminary revenue results for the year were lower than analysts were expecting. Shares declined 9.7% to $23.50.

Tilray Brands said a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business. Shares advanced 7.8% to $9.85.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 08, 2026 18:32 ET (23:32 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602319983?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-09 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602319983","market":"sh","top_or_hot":-1,"title":"Stocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. \n</p>\n<p>\n  Olin cut its fourth-quarter outlook, citing a slowdown in operations at its Freeport, Texas, facility and a decline in chlorine demand. The stock fell 7.8% to $20.80 after the bell. \n</p>\n<p>\n  Pacira BioSciences' preliminary revenue results for the year were lower than analysts were expecting. Shares declined 9.7% to $23.50. \n</p>\n<p>\n  Tilray Brands said a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business. Shares advanced 7.8% to $9.85. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2026 18:32 ET (23:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-09 07:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. \n</p>\n<p>\n  Olin cut its fourth-quarter outlook, citing a slowdown in operations at its Freeport, Texas, facility and a decline in chlorine demand. The stock fell 7.8% to $20.80 after the bell. \n</p>\n<p>\n  Pacira BioSciences' preliminary revenue results for the year were lower than analysts were expecting. Shares declined 9.7% to $23.50. \n</p>\n<p>\n  Tilray Brands said a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business. Shares advanced 7.8% to $9.85. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2026 18:32 ET (23:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1169589451.USD","symbol_name":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2602319983","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602319983","pubTimestamp":1767915120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday.Olin cut its fourth-quarter outlook, citing a slowdown in operations at its Freeport, Texas, facility and a decline in chlorine demand. The stock fell 7.8% to $20.80 after the bell.Pacira BioSciences' preliminary revenue results for the year were lower than analysts were expecting. Shares declined 9.7% to $23.50.Tilray Brands said a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business. Shares advanced 7.8% to $9.85.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK4547":"WSB热门概念","BK4157":"电子设备和仪器","BK4557":"大麻股","PCRX":"Pacira Pharmaceuticals","TLRY":"Tilray Inc.","BK4145":"电子制造服务","BK4090":"商品化工","BK4007":"制药","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4596":"哈里斯概念","OLN":"欧林","CETX":"Cemtrex Inc."},"translate_title":"值得关注的股票：Cemtrex、Olin、Pacira BioSciences、Tilray Brands","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OLN":1.5,"CETX":1.5,"TLRY":1.5,"PCRX":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. \n\n\n  Olin cut its fourth-quarter outlook, citing a slowdown in operations at its Freeport, Texas, facility and a decline in chlorine demand. The stock fell 7.8% to $20.80 after the bell. \n\n\n  Pacira BioSciences' preliminary revenue results for the year were lower than analysts were expecting. Shares declined 9.7% to $23.50. \n\n\n  Tilray Brands said a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business. Shares advanced 7.8% to $9.85. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 18:32 ET (23:32 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602319983","isCrawlerRequest":true}